MRK - Merck wins approval of RNA-based dog flu vaccine
2024-06-25 17:06:01 ET
More on Merck
- Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying
- Merck gets FDA approval for Capvaxive pneumonia vaccine (update)
- Merck's Keytruda gains approval for additional endometrial carcinoma indication
- Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference - (Transcript)
- Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript)